DuoGenic StemCells corporation (TPEX:7607)
Taiwan · Delayed Price · Currency is TWD 11.85
0.00 (0.00%)
Aug 19, 2026, 9:29 AM CST
TPEX:7607 Market Cap
TPEX:7607 has a market cap or net worth of 362.05 million as of August 18, 2026. Its market cap has increased by 16.18% in one year.
Market Cap
362.05M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
11.85
ChartMarket Cap Chart
Since May 25, 2023, TPEX:7607's market cap has decreased from 1.92B to 362.05M, a decrease of -81.19%. That is a compound annual growth rate of -40.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 19, 2026 | 362.05M | -35.77% |
| Dec 31, 2025 | 563.70M | -20.13% |
| Dec 31, 2024 | 705.77M | -35.83% |
| Dec 22, 2023 | 1.10B | -42.86% |
| May 25, 2023 | 1.92B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 584.35B |
| Caliway Biopharmaceuticals | 159.43B |
| Lin BioScience | 78.44B |
| Pell Bio-Med Technology | 68.36B |
| UniPharma | 410.04M |
| A-SPINE Asia | 394.03M |
| Welgene Biotech | 390.35M |
| Taiwan Advanced Nanotech | 387.83M |